University of Houston Studied Diabetes Medication Adherence

Researchers tracked the consistency of type 2 diabetes treatment plans for over 116,000 patients.

Updated on Sept. 22, 2026 in Diabetes

Isometric editorial illustration of a medication blister pack and water pitcher on a plain surface, representing health research. — A University of Houston study found that 71% of type 2 diabetes patients were nonadherent to their treatment plans during their first year. AI Illustration. Upload story photo >

Live Poll

Do you find it difficult to maintain a consistent schedule for your prescribed daily medications?

Researchers at the University of Houston have analyzed medication adherence patterns among 116,597 drug-naive patients with type 2 diabetes. The study found that 71% of patients followed a nonadherent trajectory during their first year of treatment.

Why it matters

Understanding how patients adhere to initial combination therapy is critical for managing chronic conditions like type 2 diabetes. This analysis helps identify which demographic groups and insurance plans are most prone to treatment gaps.

Of the 116,597 studied patients, 14,118 initiated combination therapy, which represents 12.1% of the cohort. Among all participants, 26.7% showed a rapid decline in adherence while 21.6% experienced a gradual decline.

The players

University of Houston

This is a public research university in Houston that conducts extensive studies on health outcomes and medical treatments.

The details

Using data from 2017 to 2019, the team identified four distinct patterns: adherent, gradual decline, gaps in adherence, and rapid decline. The study revealed that patients aged 55-64 were more consistent than younger adults, while those with HMO plans struggled more than patients with comprehensive coverage.

The data collection period for the study spanned from 2017 to 2019.
The research study was published in 2026.

Diabetes
Sept. 22
FDA Issued Warning Letter to Houston Empower Pharmacy
Diabetes
Sept. 21
Eli Lilly Began Construction on Houston Campus
Autism
Sept. 21
Researchers Linked Genetic Variant to Autism in Children

The Big Picture

This study follows a pattern of utilizing the Merative MarketScan research databases to conduct large-scale longitudinal analyses of patient medication behavior. It expands the understanding of how real-world data can be used to refine treatment protocols.

Patients may find that their insurance plan type or age group influences their ability to maintain a consistent treatment regimen. Doctors can use these findings to provide targeted support to those identified as high-risk for rapid medication decline.

The takeaway

Maintaining consistent medication adherence is a major hurdle for a large majority of type 2 diabetes patients beginning treatment. Healthcare providers and patients should discuss potential barriers to access, such as insurance limitations, early in the treatment planning process.